ResearcherCellular and Molecular Biotechnology Research InstituteNo recent work listed

Shuuji Mawaribuchi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0783-3243; OpenAlex author ID A5033770267. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/glycob/cwad009 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tatsuya Oda · 1 shared paper, 2023 · strength 0.19
- Paper rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma. DOI 10.1093/glycob/cwad009 ↗
Osamu Shimomura · 1 shared paper, 2023 · strength 0.19
- Paper rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma. DOI 10.1093/glycob/cwad009 ↗
Hiroaki Tateno · 1 shared paper, 2023 · strength 0.19
- Paper rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma. DOI 10.1093/glycob/cwad009 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.